Literature DB >> 21719604

KSHV: forgotten but not gone.

Patrick S Moore1, Yuan Chang.   

Abstract

Entities:  

Year:  2011        PMID: 21719604     DOI: 10.1182/blood-2011-05-350306

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

1.  CpG methylation as a tool to characterize cell-free Kaposi sarcoma herpesvirus DNA.

Authors:  Meir Shamay; Nicholas Hand; M Victor Lemas; Henry B Koon; Susan E Krown; John Wrangle; Prashant Desai; Juan Carlos Ramos; Richard F Ambinder
Journal:  J Infect Dis       Date:  2012-02-22       Impact factor: 5.226

2.  Antiviral activity of (+)-rutamarin against Kaposi's sarcoma-associated herpesvirus by inhibition of the catalytic activity of human topoisomerase II.

Authors:  Bo Xu; Ling Wang; Lorenzo González-Molleda; Yan Wang; Jun Xu; Yan Yuan
Journal:  Antimicrob Agents Chemother       Date:  2013-12-02       Impact factor: 5.191

3.  Efficient lytic induction of Kaposi's sarcoma-associated herpesvirus (KSHV) by the anthracyclines.

Authors:  Hyunju Kang; Jaehyung Song; Kwangman Choi; Hyeongki Kim; Miri Choi; So-Young Lee; Chonsaeng Kim; Sang Jun Lee; Moon Jung Song; Hyojeung Kang; Sung Hoon Back; Sang-Bae Han; Sungchan Cho
Journal:  Oncotarget       Date:  2014-09-30

4.  G-quadruplex-interacting compounds alter latent DNA replication and episomal persistence of KSHV.

Authors:  Advaitha Madireddy; Pravinkumar Purushothaman; Christopher P Loosbroock; Erle S Robertson; Carl L Schildkraut; Subhash C Verma
Journal:  Nucleic Acids Res       Date:  2016-02-02       Impact factor: 16.971

5.  Identification of viral SIM-SUMO2-interaction inhibitors for treating primary effusion lymphoma.

Authors:  Ling Ding; Qing Zhu; Feng Zhou; Hongsheng Tan; Wenjia Xu; Chengling Pan; Caixia Zhu; Yuyan Wang; Hong Zhang; Wenwei Fu; Zhikang Qian; Zhenghong Yuan; Hongxi Xu; Fang Wei; Qiliang Cai
Journal:  PLoS Pathog       Date:  2019-12-12       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.